Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Health Policy (Amsterdam, Netherlands)
|
February 7, 2015
The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention
Christian Becker, Rolf Holle, Björn Stollenwerk
Plos One
|
May 3, 2013
The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles
Yanmei Liu, Koustuv Dalal, Björn Stollenwerk
Plos One
|
December 20, 2012
Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data
Emil Victor Gruber, Stephanie Stock, Björn Stollenwerk
BMC Health Services Research
|
April 12, 2014
The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer
Florian Koerber, Raphaela Waidelich, Björn Stollenwerk, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 5, 2015
Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach
Björn Stollenwerk, Thomas Welchowski, Matthias Vogl, et al.
Journal of Medical Economics
|
January 5, 2026
Cost-effectiveness of sotorasib versus adagrasib in previously treated <i>KRAS</i> G12C-mutated advanced NSCLC: a US healthcare payer perspective
Nadia Karim, David Waterhouse, Simon Jones, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 18, 2013
Link between process and appraisal in coverage decisions: an analysis with structural equation modeling
Katharina E Fischer, Björn Stollenwerk, Wolf H Rogowski
Pharmacoeconomics
|
November 19, 2014
Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation
Alexander Mensch, Stephanie Stock, Björn Stollenwerk, et al.
Journal of Medical Economics
|
August 15, 2017
Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy
Björn Stollenwerk, Sergio Iannazzo, Kerry Cooper, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 1, 2013
Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation
Björn Stollenwerk, Afschin Gandjour, Markus Lüngen, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Health Policy (Amsterdam, Netherlands)
|
February 7, 2015
The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention
Christian Becker, Rolf Holle, Björn Stollenwerk
Plos One
|
May 3, 2013
The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles
Yanmei Liu, Koustuv Dalal, Björn Stollenwerk
Plos One
|
December 20, 2012
Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data
Emil Victor Gruber, Stephanie Stock, Björn Stollenwerk
BMC Health Services Research
|
April 12, 2014
The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer
Florian Koerber, Raphaela Waidelich, Björn Stollenwerk, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 5, 2015
Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach
Björn Stollenwerk, Thomas Welchowski, Matthias Vogl, et al.
Journal of Medical Economics
|
January 5, 2026
Cost-effectiveness of sotorasib versus adagrasib in previously treated <i>KRAS</i> G12C-mutated advanced NSCLC: a US healthcare payer perspective
Nadia Karim, David Waterhouse, Simon Jones, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 18, 2013
Link between process and appraisal in coverage decisions: an analysis with structural equation modeling
Katharina E Fischer, Björn Stollenwerk, Wolf H Rogowski
Pharmacoeconomics
|
November 19, 2014
Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation
Alexander Mensch, Stephanie Stock, Björn Stollenwerk, et al.
Journal of Medical Economics
|
August 15, 2017
Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy
Björn Stollenwerk, Sergio Iannazzo, Kerry Cooper, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 1, 2013
Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation
Björn Stollenwerk, Afschin Gandjour, Markus Lüngen, et al.
Page
of 6